Staar Surgical Co expects a delay in approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its Visian Toric ICL, its implantable lens to treat myopia and astigmatism. The PMDA has, however, not sought any more clinical trials for Visian Toric ICL. The company’s Visian ICL products are, however, on a “very quick path” to approval in the country. Visian ICL (Implantable Collamer Lens) is used to treat myopia or nearsightedness.